Pfizer Stock Purchase Agreement - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended		6 Months Ended
	Nov. 09, 2020	Nov. 09, 2020	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Net proceed from issuance of common stock					$ 49,744
Collaboration agreement revenue recognized			$ 2,187	$ 567	31,492	$ 1,155
Pfizer Inc.
Common stock estimated fair value	$ 52,000
Stock purchase agreement remaining allocated value	8,000	$ 8,000
Allocated Information Committee obligation	$ 8,000	$ 8,000
Pfizer Inc. | Collaborative Arrangement
Collaboration agreement revenue recognized			800		1,600
Deferred revenue			$ 6,000		$ 6,000
Private Placement
Issuance of common stock, net of discounts and issuance costs, Shares	5,000,000	5,000,000
Shares issued price per share	$ 12.00	$ 12.00
Net proceed from issuance of common stock	$ 60,000	$ 60,000
Common stock purchase agreement condition	The shares of common stock sold to Pfizer are subject to a one-year lock-up from closing, during which time Pfizer is prohibited from selling or otherwise disposing of such shares.